IDH1 and central nervous system cancer: Immunohistochemistry scores showed that TMEM106A is most highly expressed in high‐grade tumors, especially in IDH‐wildtype gliomas, whereas the intensity of TMEM106A staining in IDH‐mutant tumors remains comparatively subdued.